Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study Before HCT, 88 patients met morphologic criteria for complete remission (CR), ...
An interview with Dr. Valerie de Haas from Princess Máxima Center for Pediatric Oncology in the Netherlands on "Initial Diagnostic Workup of Acute Leukemia: ASCO Clinical Practice Guideline ...
Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...
In a new study published in Nature Communications, a research team at the University of Oslo have examined how cancer cells ...
New findings reveal that succinate signaling through SUCNR1 acts as a protective brake in acute myeloid leukemia. Modulating ...
“Corticosteroids are well established as a highly effective component of treatment to induce remission in ALL; thus, processes that increase endogenous corticosteroid production may be responsible for ...
Around the same time, Mack Fulwyler, an engineer working at Los Alamos National Laboratory, needed to separate particles, so he drew on existing techniques to create droplets to separate cells from a ...
Acute myeloid leukaemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in ...
Acute undifferentiated leukemia is a very rare type of aggressive leukemia — a type of cancer. It’s a very serious condition because researchers don’t know much about it. Leukemia is a type of cancer ...